CDKN2A and leukemia: Up-regulated DNMTs may contribute to the pathogenesis of leukemia by inducing aberrant regional hypermethylation of tumor suppressor genes such as p73, JunB, p16, p57kip2, 14-3-3 and BRCA-1.